Skip to main content
. 2013 Nov 12;2013:375613. doi: 10.1155/2013/375613

Table 4.

Risk factors for overall complications after CSEMS deployment (univariate analysis).

Complication (+)
(n = 13)
Complication ()
(n = 66)
P value OR (95% CI)
Female gender 7 32 0.770 1.2 (0.38–4.1)
Age (<60 years) 4 4 0.022 6.9 (1.5–33)
Nonpancreatic cancer 4 2 0.006 14 (2.3–89)
Periampullary diverticulum 3 8 0.377 2.2 (0.49–9.6)
Non-EST 6 35 0.765 0.76 (0.23–2.5)
Fully covered type stent 5 17 0.499 1.8 (0.52–6.3)
Pancreatic duct injection 3 17 1.000 0.87 (0.21–3.5)
Biopsy of the bile duct 0 4 1.000
Cytology of bile juice 1 5 1.000 1.0 (0.11–9.5)
Intraductal ultrasonography 1 2 0.421 2.7 (0.22–32)
Procedure time (>45 minutes) 2 8 0.666 1.3 (0.2–7.1)

CSEMS: covered self-expandable metal stent. EST: endoscopic sphincterotomy.